The Legal Issue
The core legal issue before the Delhi High Court was whether the marks 'ACNE SCAR', 'ACNE+SCAR', and 'ACNESCAR' were deceptively similar to Mankind Pharma's registered trademark 'ACNESTAR', thereby constituting trademark infringement under The Trademarks Act, 1999. Mankind Pharma sought an interim injunction to prevent the defendants from using these marks for their pharmaceutical products, arguing that such use would cause confusion among consumers and dilute the distinctiveness of their established brand.
Court's Reasoning
The Delhi High Court, after considering the arguments, found a prima facie case of trademark infringement. The Court observed that the competing marks shared significant phonetic and visual similarities, particularly the dominant 'ACNE' prefix and the 'STAR'/'SCAR' suffixes, which could easily lead to confusion among consumers, especially given that the products were identical (dermatological preparations for acne). The Court applied the test of deceptive similarity, noting that even a slight variation might not be enough to distinguish marks if the overall impression is similar. The Court also considered the goodwill and reputation associated with Mankind's 'ACNESTAR' mark, which had been extensively used and promoted. Consequently, the Court concluded that the balance of convenience lay in favour of Mankind Pharma, and irreparable harm would be caused if the injunction was not granted. The Court directed the defendants to recall all existing stock bearing the infringing marks within two months.
Why It Matters
This decision is significant for trademark owners, particularly in the pharmaceutical sector, where brand names are crucial for product identification and consumer trust. It reinforces the principle that even minor variations in a mark may not prevent a finding of deceptive similarity if the overall impression is likely to confuse consumers. The order for the recall of existing stock underscores the Court's commitment to providing comprehensive relief in cases of clear infringement, ensuring that infringing products are removed from the market. This ruling serves as a strong deterrent against the adoption of similar marks and emphasizes the importance of protecting registered trademarks to maintain market integrity and prevent unfair competition.